Prestige Consumer Healthcare Inc. (PBH) has a consensus analyst rating of Buy, based on 17 analysts covering the stock. Of those, 12 recommend buying, 3 recommend holding, and 2 recommend selling.
The analyst consensus price target for PBH is $66.00, representing a +16.5% upside from the current price of $56.66. Price targets range from a low of $66.00 to a high of $66.00.